Study | No. events/ no. exposed | No. events/ no. unexposed | Measure of association | Unadjusted estimate (95% CI) | Adjusted estimate (95% CI) | Covariates (adjusted for or matched) |
---|---|---|---|---|---|---|
Cohort studies | ||||||
Jackson et al. 200412 | – | – | HR | – | 1.52 (1.29–1.78) | Age, sex, smoking status, CHF, ischemic heart disease, cancer, dementia, stroke, COPD, asthma, renal disease, use of prednisone or other immunosuppressive medication, no. of outpatient visits in the previous year, hospital admission for pneumonia in in the previous year, home oxygen therapy, receipt of home health care |
Muller et al. 20053 | – | – | OR | 1.31 (1.15–1.50) | 1.30 (1.11–1.52) | Age, sex, asthma, pulmonary disease (including tuberculosis, acute bronchitis and asthma), insurance type, cardiovascular disease, peripheral neuropathy, neurologic disease |
O’Meara et al. 200513 | – | – | Risk ratio | – | 1.34 (1.05–1.70) | Age, race, education level, smoking status, prior vaccination for pneumonia, vaccination for influenza in the previous year, FEV1, FVC, maximal inspiratory pressure, 3MSE score, history of: MI, angina pectoris, CAD, claudication, CHF, CVA, COPD, pneumonia |
Benfield et al. 20075 | 90/353 | 1104/9710 | HR | 2.55 (1.86–3.29) | 1.75 (1.23–2.48) | Age, sex, smoking status, SES (education, income), cholesterol, triacylglycerol, hypertension, physical activity, lung function |
Ehrlich et al. 201014 | – | – | HR | – | 1.92 (1.84–1.99) | Age, sex, smoking status, race or ethnicity, education, alcohol, BMI, no. of outpatient visits occurring in the 12 mo before baseline |
Hamilton et al. 20136 | 181/1294 | 435/5156 | Rate ratio | 1.86 (1.55–2.21) | – | – |
Seminog and Goldacre 201310 (LHES) | – | – | Rate ratio | – | 1.68 (1.65–1.71) | Age, sex, the time period in single calendar years, SES (region of residence deprivation score) |
Seminog and Goldacre 201310 (ORLS1) | – | – | Rate ratio | – | 1.87 (1.72–2.04) | Age, sex, the time period in single calendar years, SES (district of residence) |
Seminog and Goldacre 201310 (ORLS2) | – | – | Rate ratio | – | 1.76 (1.60–1.92) | Age, sex, the time period in single calendar years, SES (district of residence) |
Hine et al. 20178 | 34 278* | 613 052† | OR | – | 1.43 (1.18–1.74) | Age, sex, smoking status, SES, comorbidities, general practice |
López-de-Andrés et al. 201715 | NR/223 715 | NR/677 621 | Rate ratio | 1.66 (1.65–1.67) | Age, sex, year of discharge | |
Ray et al. 201716 | 7/47 | 15/292 | OR | 3.23 (1.24–8.38) | – | – |
Williams et al. 201717 | – | – | OR | – | 1.74 (1.44–2.10) | Age, sex, smoking status, BMI, prior diagnosis of pneumonia, exacerbation frequency, pharmacotherapy, comorbidities, GOLD stage |
Case–control studies | ||||||
Farr et al. 200018 | – | – | OR | 2.50 (0.34–14.11) | – | – |
Thomsen et al. 20049 | 53/351 | 545/6227 | OR | 1.9 (1.4–2.6) | 1.5 (1.1–2.0) | Age (matched), sex (matched), Charlson Comorbidity Index score, alcohol-related disease |
van de Garde et al. 200619 | 134/393 | 974/4532 | OR | 1.88 (1.66–2.10) | – | – |
Kornum et al. 20087 | 4489/32 975 | 29 750/ 343 654 | OR | 1.68 (1.62–1.74) | 1.26 (1.21–1.31) | Age (matched), sex (matched), SES (marital status, degree of urbanization) |
Note: BMI = body mass index, CAD = coronary artery disease, CHF = congestive heart failure, CI = confidence interval, COPD = chronic obstructive pulmonary disease, CVA = cerebrovascular accident, FEV1 = forced expiratory volume in 1 second, FVC = forced vital capacity, GOLD = Global Initiative on Obstructive Lung Disease, HR = hazard ratio, LHES = Linked English Hospital Episodes Statistics, MI = myocardial infarction, NR = not reported, OR = odds ratio, ORLS = Oxford Record Linkage Study, SES = socioeconomic status, 3MSE = Modified Mini-Mental State Examination.
↵* Total no. of exposed patients.
↵† Total no. of unexposed patients.